The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children

Journal of Infectious Diseases

Volumn 184, Issue 9, 2001, Pages 1192-1196

  Hanekom, Willem A ^a   Hughes, Jane ^b   Haslett, Patrick A J ^a   Apolles, Patty ^b   Ganiso, Vuyiseka ^b   Allin, Rene ^b   Goddard, Elizabeth ^b   Hussey, Gregory D ^b   Kaplan, Gilla ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CD38 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CELGENE; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HLA DR ANTIGEN; INTERLEUKIN 12; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; IMMUNOMODULATION; INFANT; MALE; MONOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; VIRUS LOAD;

ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; LYMPHOCYTE ACTIVATION; MALE; PILOT PROJECTS; THALIDOMIDE; VIRAL LOAD;

EID: 0035500656     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323806     Document Type: Article

References (15)

1. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
2. Thalidomide for the treatment of AIDS-associated wasting
3. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placebo-controlled clinical trial
4. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum
5. Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients
6. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis
7. Immune stimulation in scleroderma patients treated with thalidomide
8. + subset
9. Steroid-resistant idiopathic esophageal ulcer in a child with AIDS
10. Thalidomide treatment of mucosal ulcerations in HIV infection
11. Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide
12. Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype
13. 1994 Revised classification guidelines for human immunodeficiency virus infection in children less than 13 years of age
14. Parotid gland swelling in HIV diffuse infiltrative CD8 lymphocytosis syndrome